about
The actin cytoskeleton as a barrier to virus infection of polarized epithelial cellsExploration of panviral proteome: high-throughput cloning and functional implications in virus-host interactionsWhat's unique about acute pancreatitis in children: risk factors, diagnosis and management.Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway.Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditisA single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells.Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.The conspiracy of autophagy, stress and inflammation in acute pancreatitisNovel N-benzenesulfonyl sophocarpinol derivatives as coxsackie B virus inhibitors.Synthesis of novel purine-based coxsackievirus inhibitors bearing polycylic substituents at the N-9 position.Discovery of itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A.Expression of human decay-accelerating factor on intestinal epithelium of transgenic mice does not facilitate infection by the enteral routeDynamics of molecular responses to coxsackievirus B4 infection differentiate between resolution and progression of acute pancreatitis.Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinantsWild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivoIdentification of the interaction of VP1 with GM130 which may implicate in the pathogenesis of CVB3-induced acute pancreatitis.Complete genome sequence of a coxsackievirus B3 isolated from a Sichuan snub-nosed monkeySlam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditisIs alcoholic pancreatitis associated with enteroviral infection?Lipid raft- and SRC family kinase-dependent entry of coxsackievirus B into human placental trophoblasts.IL-10 is pathogenic during the development of coxsackievirus B4-induced chronic pancreatitis.Echovirus 6 Infects Human Exocrine and Endocrine Pancreatic Cells and Induces Pro-Inflammatory Innate Immune ResponseDo Animal Models of Acute Pancreatitis Reproduce Human Disease?SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3.Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesisCoxsackievirus B3 protease 3C: expression, purification, crystallization and preliminary structural insights.Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis.Coxsackievirus B escapes the infected cell in ejected mitophagosomes.TLR3 is required for survival following Coxsackievirus B3 infection by driving T lymphocyte activation and polarization: The role of dendritic cells.Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic acinar cells in vivo.The cytotoxicity of coxsackievirus B3 is associated with a blockage of autophagic flux mediated by reduced syntaxin 17 expression.
P2860
Q27015995-460E4804-8507-4BED-9613-44409BF93D87Q28116349-12BC5E09-8DC5-4DA7-96C4-F1E0EDC8AD02Q30235282-2606A280-E979-434A-BDAC-06C222DC04D1Q33510911-58044FCC-1414-4061-973F-FB160BD49BE1Q33686890-69024F96-0C75-44A3-9E07-C151CD6408F3Q33828989-87493C1B-01F1-446C-90EC-88A8C37881B6Q33877444-5E30E57D-CA57-4AE6-ABE4-D56464A4CDB6Q34608956-64AAB1C2-A3B7-4192-B384-51C6C7BDD4D4Q34915977-5D728E9A-5DA2-4475-A097-EEC8E60419F5Q35086749-CBE71FF6-829C-4A22-99EB-542EF6E16FE7Q35126871-A5DD7350-866A-4A93-9385-8ABA4342823CQ35386030-A8DC9B8D-E162-417E-94E9-AF4A9EC5CEB9Q35641009-2F606385-6623-4400-8D0B-13D3F9DBDC80Q35854730-7871B58F-3A7B-4417-A463-8B6203507731Q35973518-5192BC6D-F6C7-4F26-90FA-A967866D972CQ35981115-5620D079-9354-49B4-84DA-6B4956D7853EQ36002614-F51A9AA0-F850-4045-8362-1C2601B8DF72Q36397503-C738F7CE-FEAC-4BE1-B3C5-4D39664E6A9DQ36582861-B33533B1-8BC9-4629-96C2-4C015462BA12Q36975016-370E6091-BD7E-4D0C-AA1A-73674BC7C245Q37036674-C7928B4D-41A9-4256-90D5-AF4392F32E8FQ37439030-946714E1-2C47-471E-A58A-AACB28ED6A54Q37676083-4E48879C-2D4C-44A3-919D-677F7FBD84A6Q38656177-B456ECFC-8608-4674-9E55-DAC02B206A68Q38794993-8412EE79-1999-4294-90C8-CCE2185E8F0FQ39450672-9AA410E9-D074-42DC-8735-C200285E68BAQ39743300-60A1F8D7-2850-4235-B4F5-877252C28D12Q40441657-A8C14F05-66C2-466F-9C9F-64183B8AF947Q41834966-2389008E-B59F-47F1-B323-057333DD2753Q41924210-BCB94DAE-9F3F-4577-A46E-E52F8072829AQ41925485-2C5BE5B8-68B9-4DB7-BE13-E5A0DEACFDB5Q42281820-5EFF29AA-7156-45E5-9DBF-7E3BB4AD9AFCQ42375433-35ED5579-DAC4-4CB6-8C40-1876EE80BDB1Q52694954-103934E9-BCC0-4424-84E4-914DE64FCF8F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Coxsackievirus-induced pancreatitis.
@ast
Coxsackievirus-induced pancreatitis.
@en
type
label
Coxsackievirus-induced pancreatitis.
@ast
Coxsackievirus-induced pancreatitis.
@en
prefLabel
Coxsackievirus-induced pancreatitis.
@ast
Coxsackievirus-induced pancreatitis.
@en
P356
P1433
P1476
Coxsackievirus-induced pancreatitis.
@en
P2093
Arlene I Ramsingh
Sally Huber
P304
P356
10.1089/VIM.2004.17.358
P577
2004-01-01T00:00:00Z